Brokerages Set Adient plc (NYSE:ADNT) Target Price at $20.88

Shares of Adient plc (NYSE:ADNTGet Free Report) have received an average recommendation of “Reduce” from the nine analysts that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation and seven have given a hold recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $20.88.

A number of equities research analysts have weighed in on the stock. Morgan Stanley dropped their price target on shares of Adient from $19.00 to $17.00 and set an “underweight” rating for the company in a research report on Monday, March 3rd. JPMorgan Chase & Co. dropped their target price on shares of Adient from $24.00 to $21.00 and set a “neutral” rating for the company in a report on Monday, January 27th. UBS Group upped their price target on Adient from $19.00 to $20.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 29th. Wells Fargo & Company lowered Adient from an “overweight” rating to an “equal weight” rating and lowered their price target for the stock from $27.00 to $20.00 in a research report on Monday, December 16th. Finally, StockNews.com downgraded Adient from a “buy” rating to a “hold” rating in a report on Wednesday, March 5th.

Check Out Our Latest Stock Report on ADNT

Institutional Trading of Adient

Hedge funds have recently modified their holdings of the stock. Victory Capital Management Inc. grew its stake in Adient by 8.4% during the 3rd quarter. Victory Capital Management Inc. now owns 20,977 shares of the company’s stock worth $473,000 after purchasing an additional 1,633 shares in the last quarter. Thrivent Financial for Lutherans boosted its stake in shares of Adient by 202.8% in the 3rd quarter. Thrivent Financial for Lutherans now owns 69,831 shares of the company’s stock valued at $1,576,000 after buying an additional 46,766 shares during the period. Intech Investment Management LLC acquired a new position in shares of Adient during the third quarter worth about $725,000. Charles Schwab Investment Management Inc. increased its stake in shares of Adient by 6.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 963,446 shares of the company’s stock worth $21,745,000 after buying an additional 55,387 shares during the period. Finally, Citigroup Inc. raised its holdings in Adient by 30.2% in the third quarter. Citigroup Inc. now owns 265,534 shares of the company’s stock valued at $5,993,000 after acquiring an additional 61,531 shares in the last quarter. 92.44% of the stock is currently owned by institutional investors and hedge funds.

Adient Price Performance

ADNT stock opened at $15.09 on Monday. Adient has a 52-week low of $13.34 and a 52-week high of $33.74. The company has a quick ratio of 0.86, a current ratio of 1.08 and a debt-to-equity ratio of 1.11. The stock has a market cap of $1.27 billion, a price-to-earnings ratio of 754.25, a price-to-earnings-growth ratio of 0.34 and a beta of 2.27. The business has a fifty day moving average of $16.11 and a two-hundred day moving average of $18.58.

Adient (NYSE:ADNTGet Free Report) last released its quarterly earnings results on Tuesday, January 28th. The company reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.05). Adient had a positive return on equity of 6.94% and a negative net margin of 0.01%. During the same period in the previous year, the firm earned $0.31 EPS. As a group, research analysts anticipate that Adient will post 1.76 earnings per share for the current year.

About Adient

(Get Free Report

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.

Featured Stories

Analyst Recommendations for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.